LGALS1 and neoplasm: Thiodigalactoside (TDG) is a synthetic disaccharide with a high affinity for galectin-1, thereby blocking galectin-1-mediated tumor angiogenesis and immune response, and preventing oxidative stress in a non-selective manner.